Correct, this is the same treatment. However, it has reached very few of the 100,000 sickle cell patients in the US. Story here: https://www.wired.com/story/t

Correct, this is the same treatment. However, it has reached very few of the 100,000 sickle cell patients in the US. Story here: https://www.wired.com/story/the-worlds-first-crispr-drug-gets-a-slow-start-sickle-cell-beta-thalassemia-vertex/ https://www.wired.com/story/the-worlds-first-crispr-drug-get...